Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Hemorrhagic Stroke in an Atorvastatin Stroke-Prevention Trial

Analysis of the hemorrhagic-stroke events in the SPARCL study demonstrates higher risk in certain subgroups, independent of the statin.

Sign In

Don't yet have a username or password?

Journal Watch e-mail alerts and unlimited online access to articles 6 months after publication.

Full, immediate online access to all Journal Watch content and services.

Already a subscriber? Activate your subscription to receive full online access.

Get full site access with a 7-day site pass for $19